Pragnesh Donga RAC

15+ years’ global regulatory leadership across small molecules, biologics, ADCs, biosimilars, and medical devices. Managed 17 US INDs plus CTAs in the EU & Australia; led NDAs, BLAs, biosimilar filings. Secured orphan-drug, Fast Track, and PRIME designations and steered FDA, EMA, ANVISA inspections and negotiations.